Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 686 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FDA approves new dose strength of Exalgo drug

Exalgo is used to treat moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time. Exalgo uses OROS technology to

Cangene extends biodefence contracts with US

The company has modified contract with the US Department of Health and Human Services for the development and supply of Anthrax Immune Globulin Intravenous (AIGIV). The modification extends

Millstone to expand US operations

The new facility is expected to have150,000 ft² of operational space for mechanical inspection, loaner kit processing, bone/tissue storage, packaging services and distribution. The growing needs of customers

Bosch introduces new capsule filling machines

The new design of GKF 702 provides improved ergonomics and accessibility to meet the growing needs in pharmaceutical industry for flexibility, according to the company. The unit can

US FDA approves Gilead HIV-1 infection tablet

Stribild is a complete once-daily single tablet regimen for HIV-1 infection to treat naïve adults. Stribild is made up of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate. Stribild